Javascript must be enabled to continue!
Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
View through CrossRef
Abstract
The physiological mechanisms that can restore biological activity of mutant p53 is an area of high interest given that mutant p53 expression is observed in one third of prostate cancer and more than 50% of all cancers. Here we demonstrate that Id4 (inhibitor of differentiation-4) a dominant negative regulator of bHLH transcription factors can restore the mutant p53 transcriptional activity in prostate cancer cells. Id4 is highly expressed in the normal prostate and decreased in prostate cancer due to promoter hypermethylation. Prostate cancer cell lines: DU145 harbors mutant p53 also lack Id4 expression, and LNCaP cells with wild type p53 express Id4, whereas PC3 cells are null for p53 and express low levels of Id4. The p53 mutants (P223L and V274F) in DU145 cells are within the DNA binding domain and abrogate p53 transcriptional activity due structural de-stabilization and/or DNA interactions. Ectopic expression of Id4 in DU145 cells resulted in increased apoptosis and expression of BAX, PUMA and p21, the transcriptional targets of p53. DNA binding, p53 luciferase reporter studies and ChIP analysis demonstrated that mutant p53 gains Id4 dependent DNA binding and transcriptional activity in part due to CBP/p300 dependent acetylation of p53 at lysine 373. Loss of Id4 in LNCaP cells also abrogated wild type p53 DNA binding and transcriptional activity with concomitant loss of CBP/p300 requirement and decreased acetylation of p53. To further elucidate Id4 dependent restoration of biological activity of p53 we stably transfected p53-null cell line PC3, which has endogenous Id4 with mutant p53 mimicking DU145 cells. mRNA, protein levels and apoptosis assays were used to determine the effects on cell death and to determine if mutant p53 had the ability to transactivate upstream/downstream targets (MDM2, PUMA, and p21). Our results indicate that mutant p53 in PC3 cells were able to induce expression of downstream targets as well as effect biological processes such as apoptosis and cell cycle arrest. Also, post-translational modifications on residues lys320 and lys373 indicated activation of mutant p53. Collectively, based on our studies we demonstrate that Id4 promotes post-translational modifications of p53, which in turn regulates p53 transcriptional activity. NIH grant #R01CA128914
Citation Format: Derrick Jerone Morton. Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 599. doi:10.1158/1538-7445.AM2014-599
Title: Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
Description:
Abstract
The physiological mechanisms that can restore biological activity of mutant p53 is an area of high interest given that mutant p53 expression is observed in one third of prostate cancer and more than 50% of all cancers.
Here we demonstrate that Id4 (inhibitor of differentiation-4) a dominant negative regulator of bHLH transcription factors can restore the mutant p53 transcriptional activity in prostate cancer cells.
Id4 is highly expressed in the normal prostate and decreased in prostate cancer due to promoter hypermethylation.
Prostate cancer cell lines: DU145 harbors mutant p53 also lack Id4 expression, and LNCaP cells with wild type p53 express Id4, whereas PC3 cells are null for p53 and express low levels of Id4.
The p53 mutants (P223L and V274F) in DU145 cells are within the DNA binding domain and abrogate p53 transcriptional activity due structural de-stabilization and/or DNA interactions.
Ectopic expression of Id4 in DU145 cells resulted in increased apoptosis and expression of BAX, PUMA and p21, the transcriptional targets of p53.
DNA binding, p53 luciferase reporter studies and ChIP analysis demonstrated that mutant p53 gains Id4 dependent DNA binding and transcriptional activity in part due to CBP/p300 dependent acetylation of p53 at lysine 373.
Loss of Id4 in LNCaP cells also abrogated wild type p53 DNA binding and transcriptional activity with concomitant loss of CBP/p300 requirement and decreased acetylation of p53.
To further elucidate Id4 dependent restoration of biological activity of p53 we stably transfected p53-null cell line PC3, which has endogenous Id4 with mutant p53 mimicking DU145 cells.
mRNA, protein levels and apoptosis assays were used to determine the effects on cell death and to determine if mutant p53 had the ability to transactivate upstream/downstream targets (MDM2, PUMA, and p21).
Our results indicate that mutant p53 in PC3 cells were able to induce expression of downstream targets as well as effect biological processes such as apoptosis and cell cycle arrest.
Also, post-translational modifications on residues lys320 and lys373 indicated activation of mutant p53.
Collectively, based on our studies we demonstrate that Id4 promotes post-translational modifications of p53, which in turn regulates p53 transcriptional activity.
NIH grant #R01CA128914
Citation Format: Derrick Jerone Morton.
Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner.
[abstract].
In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA.
Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 599.
doi:10.
1158/1538-7445.
AM2014-599.
Related Results
Id4 dependent acetylation restores mutant-p53 transcriptional activity
Id4 dependent acetylation restores mutant-p53 transcriptional activity
Abstract
Background
The mechanisms that can restore biological activity of mutant p53 are an area of high interest given that mutant p53 expressi...
Abstract 1176: Bypassing the dominant-negative effect of mutant p53 in cancer cells
Abstract 1176: Bypassing the dominant-negative effect of mutant p53 in cancer cells
Abstract
The tumor suppressor p53 is mutated in more than 50% of all cancers. The transcriptional activity of p53 depends on localization to the nucleus and formatio...
Study of the regulatory mechanism involved in dark-induced Postharvest leaf senescence
Study of the regulatory mechanism involved in dark-induced Postharvest leaf senescence
Postharvest leaf senescence contributes to quality losses in flowers and leafy vegetables. The general goal of this research project was to investigate the regulatory mechanisms in...
Abstract A16: Wnt antagonist SFRP1 functions as secreted mediator of senescence
Abstract A16: Wnt antagonist SFRP1 functions as secreted mediator of senescence
Abstract
The purpose of this study was 1) to identify the mediator(s) of senescence that are secreted from senescent cells and induce senescence in an autocrine and ...
Structural and mechanistic diversity in p53-mediated regulation of organismal longevity across taxonomical orders
Structural and mechanistic diversity in p53-mediated regulation of organismal longevity across taxonomical orders
Abstract
The accumulation of senescent cells induces several aging phenotypes, and the p53 tumor suppressor protein regulates one of the two known cellular senescen...
Abstract 829: p53 dimers elicit tumor suppressive activities through an altered metabolic program
Abstract 829: p53 dimers elicit tumor suppressive activities through an altered metabolic program
Abstract
p53 is the most frequently mutated gene in human cancer. As a tetrameric transcription factor, mutation of the p53 Tetramerization Domain (TD) is a mechanis...
Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract
Cancer cases are on the rise globally requiring a deeper understanding of the disease and identification of novel therapeutic targets. Mutations in genes of...
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
Abstract
Abstract 1490
Background:
The tumor suppressor p53 is frequently mutated in human cancer, including acut...

